<<With market growth, GENova's licensing fees could grow to $700 million per annum [LOL^2].>>
Note the similar reasoning in this possibly less serious press release from Codeweavers, developer of the Crossover Windows software for the Mac:
CODEWEAVERS TO OVERTAKE MICROSOFT BY 2018 Current Sales Trend Indicates Gadfly Open Source Developers Will Be Nation's Largest Provider of Windows Technology; Microsoft Imperiled CodeWeavers Offers to Buy Microsoft Campus "On Credit"
SAINT PAUL, Minn. (July 24, 2009) – CodeWeavers, Inc. today announced that recent sales trends position them to overtake Microsoft's operating revenue in 2018, based on Microsoft's fourth quarter report dated July 23, 2009 showing a 17 percent decrease in revenue quarter over quarter.
Yesterday while eating lunch at his desk, CodeWeavers President and CEO Jeremy White spied a story reporting that Microsoft's quarterly revenues had decreased 17 percent - leading to the first year-over-year decline in their 34-year history. "I nearly spit a mouthful of a Jimmy John's Turkey Tom sandwich onto my desk in excitement and awe," he said, "because our own revenues had grown by more than 20 percent during our fourth quarter."
Quickly firing up Microsoft Excel (which was incidentally running on Linux via CodeWeavers' revolutionary CrossOver product), White plotted out the point of intersection in which - current trends continuing - CodeWeavers would overtake Microsoft in sales.
GVBP: I see the message board has opened up here for this Herculean effort to turn a Christian travel agency into a biotech superpower. It should be an interesting place for a while.
i like the description on google finance: Genova Biotherapeutics, Inc., formerly Kinder Travel, Inc., is a travel agency offering a range of travel services, including corporate travel, vacations, cruise holidays, and group tours. right to the poor house.
News 
Market Data 
Discover 
